PLVAP and hepatocellular carcinoma: The co-localization and interaction of POSTN + ECM-secreting CAFs, FOLR2 + TAMs, and PLVAP + ECs promote the progression of HCC and recruit Tregs to attenuate the response to immunotherapy [102].